These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20637998)

  • 61. Natural history of thyroid associated ophthalmopathy.
    Perros P; Crombie AL; Kendall-Taylor P
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):45-50. PubMed ID: 7889631
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Management of dysthyroid eye disease.
    Fells P
    Br J Ophthalmol; 1991 Apr; 75(4):245-6. PubMed ID: 1902375
    [No Abstract]   [Full Text] [Related]  

  • 63. [LIFESTYLE ADJUSTMENT AS THERAPEUTIC TOOL IN THYROID EYE DISEASE].
    Vashdi I; Gur Z
    Harefuah; 2022 Apr; 161(4):223-227. PubMed ID: 35466606
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thyroid eye disease: a review.
    Weiler DL
    Clin Exp Optom; 2017 Jan; 100(1):20-25. PubMed ID: 27701774
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Imaging Investigation of Thyroid Eye Disease.
    Siakallis LC; Uddin JM; Miszkiel KA
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S41-S51. PubMed ID: 29905640
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevalence of thyroid eye disease in Graves' disease: A meta-analysis and systematic review.
    Chin YH; Ng CH; Lee MH; Koh JWH; Kiew J; Yang SP; Sundar G; Khoo CM
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):363-374. PubMed ID: 32691849
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Somatostatin receptor scintigraphy in thyroid eye disease.
    Kahaly GJ; Förster GJ
    Thyroid; 1998 Jun; 8(6):549-52. PubMed ID: 9669296
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk Factors of Thyroid Eye Disease.
    Lee MH; Chin YH; Ng CH; Nistala KRY; Ow ZGW; Sundar G; Yang SP; Khoo CM
    Endocr Pract; 2021 Mar; 27(3):245-253. PubMed ID: 33655885
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
    Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
    Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thyroid eye disease.
    Perros P; Neoh C; Dickinson J
    BMJ; 2009 Mar; 338():b560. PubMed ID: 19270020
    [No Abstract]   [Full Text] [Related]  

  • 71. Thyroid eye disease: Redefining its management-A review.
    Jain AP; Jaru-Ampornpan P; Douglas RS
    Clin Exp Ophthalmol; 2021 Mar; 49(2):203-211. PubMed ID: 33484076
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic factors of restrictive myopathy in thyroid eye disease.
    Choi JH; Noh H; Kim YD; Woo KI
    Sci Rep; 2021 Jul; 11(1):13781. PubMed ID: 34215786
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cigarette smoking and thyroid eye disease: a systematic review.
    Thornton J; Kelly SP; Harrison RA; Edwards R
    Eye (Lond); 2007 Sep; 21(9):1135-45. PubMed ID: 16980921
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ophthalmologic aspects of thyroid-related orbitopathy.
    Gladstone GJ
    Endocrinol Metab Clin North Am; 1998 Mar; 27(1):91-100. PubMed ID: 9534030
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phenotypes of Thyroid Eye Disease.
    Uddin JM; Rubinstein T; Hamed-Azzam S
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S28-S33. PubMed ID: 29905636
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Role of the Immune Response in the Pathogenesis of Thyroid Eye Disease: A Reassessment.
    Rosenbaum JT; Choi D; Wong A; Wilson DJ; Grossniklaus HE; Harrington CA; Dailey RA; Ng JD; Steele EA; Czyz CN; Foster JA; Tse D; Alabiad C; Dubovy S; Parekh PK; Harris GJ; Kazim M; Patel PJ; White VA; Dolman PJ; Edward DP; Alkatan HM; Al Hussain H; Selva D; Yeatts RP; Korn BS; Kikkawa DO; Stauffer P; Planck SR
    PLoS One; 2015; 10(9):e0137654. PubMed ID: 26371757
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Role of Biological Agents and Immunomodulators in Treatment Strategies for Thyroid Eye Disease: An Evidence-based Review.
    Ginter A; Migliori ME
    R I Med J (2013); 2016 Jun; 99(6):26-9. PubMed ID: 27247969
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Thyroid eye disease: what is new to know?
    Li Z; Cestari DM; Fortin E
    Curr Opin Ophthalmol; 2018 Nov; 29(6):528-534. PubMed ID: 30124533
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Thyroid eye disease.
    Hsu HJ; Hsu CK; Chen TS; Hsu CH
    QJM; 2016 Jan; 109(1):67-8. PubMed ID: 26450988
    [No Abstract]   [Full Text] [Related]  

  • 80. Novel thermal imaging analysis technique for detecting inflammation in thyroid eye disease.
    Di Maria C; Allen J; Dickinson J; Neoh C; Perros P
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4600-6. PubMed ID: 25238202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.